Literature DB >> 30277115

Panoramic view of common fusion genes in a large cohort of Chinese de novo acute myeloid leukemia patients.

Xue Chen1, Fang Wang1, Yang Zhang1, Mangju Wang2, Wenjun Tian3, Wen Teng1, Xiaoli Ma1, Lei Guo1, Jiancheng Fang1, Ying Zhang2, Ping Zhu2, Hongxing Liu1,4.   

Abstract

Fusion genes are major molecular biological abnormalities in hematological malignancies. This study aimed to depict the common recurrent gene-fusion landscape in acute myeloid leukemia (AML). 3135 de novo AML cases were enrolled and 36 recurrent fusion genes were assessed using multiplex-nested RT-PCR. Twenty-three distinct fusion genes were detected in 1292 (41.21%) cases. The incidence of fusion genes was higher in pediatric AML than in adult cases. The pediatric patients had higher incidences of RUNX1-RUNX1T1, KMT2A-MLLT3, KMT2A-MLLT10, KMT2A-MLLT11, KMT2A-MLLT6, and FUS-ERG, whereas KMT2A-PTD was more common in adult patients. The occurrence of molecular abnormalities involving the KMT2A gene and CBFB-MYH11 was lower in Chinese pediatric AML compared to Western reports. The incidence of RUNX1-RUNX1T1 was higher in both pediatric and adult patients in our study than in Western countries. This study provides a genetic landscape of common fusion genes in Chinese AML and confirms different incidences between age groups and races.

Entities:  

Keywords:  Acute myeloid leukemia; adult; fusion genes; pediatric

Mesh:

Substances:

Year:  2018        PMID: 30277115     DOI: 10.1080/10428194.2018.1516876

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  Characterization of Altered Gene Expression and Histone Methylation in Peripheral Blood Mononuclear Cells Regulating Inflammation in COVID-19 Patients.

Authors:  Xiaoming Yang; Alex C Rutkovsky; Juhua Zhou; Yin Zhong; Julian Reese; Timothy Schnell; Helmut Albrecht; William B Owens; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2022-04-04       Impact factor: 5.426

2.  p210BCR-ABL1- Chronic myeloid leukemia presents with monocytosis.

Authors:  Xiaofei Wang; Fei Wang; Zie Wang; Yuantang Li; Devin Wang; Huanling Wu; Bingchang Zhang
Journal:  Clin Case Rep       Date:  2020-03-09

3.  Identification of RNPC3 as a novel JAK2 fusion partner gene in B-acute lymphoblastic leukemia refractory to combination therapy including ruxolitinib.

Authors:  Xue Chen; Fang Wang; Yang Zhang; Xiaoli Ma; Mingyue Liu; Panxiang Cao; Lin Zhou; Lan Wang; Xian Zhang; Tong Wang; Hongxing Liu
Journal:  Mol Genet Genomic Med       Date:  2019-12-30       Impact factor: 2.183

4.  Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report.

Authors:  Wenyi Zhang; Hainan Wang; Peilei Zhang; Hongliang Li; Xiaoli Ma; Hongxing Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-29       Impact factor: 2.590

5.  The First Reported Case of Allogenic Hematopoietic Stem Cell Transplantation for CML Blast Phase (Monocytic Lineage) in the Tyrosine Kinase Inhibitor Era.

Authors:  Shinya Yamada; Kotaro Arita; Yukio Kondo; Shuichi Mizuta; Hirokazu Okumura
Journal:  Case Rep Oncol       Date:  2022-05-16

6.  Development and validation of a prognostic scoring model to risk stratify childhood acute myeloid leukaemia.

Authors:  Jun Li; Lipeng Liu; Ranran Zhang; Yang Wan; Xiaowen Gong; Li Zhang; Wenyu Yang; Xiaojuan Chen; Yao Zou; Yumei Chen; Ye Guo; Min Ruan; Xiaofan Zhu
Journal:  Br J Haematol       Date:  2022-07-25       Impact factor: 8.615

7.  MLLT6 maintains PD-L1 expression and mediates tumor immune resistance.

Authors:  Sandeep Sreevalsan; Marietta Döring; Maciej Paszkowski-Rogacz; Melanie Brux; Carolina Blanck; Marten Meyer; Frank Momburg; Frank Buchholz; Mirko Theis
Journal:  EMBO Rep       Date:  2020-10-15       Impact factor: 9.071

8.  Fusion gene map of acute leukemia revealed by transcriptome sequencing of a consecutive cohort of 1000 cases in a single center.

Authors:  Xue Chen; Fang Wang; Yang Zhang; Xiaoli Ma; Panxiang Cao; Lili Yuan; Lan Wang; Jiaqi Chen; Xiaosu Zhou; Qisheng Wu; Ming Liu; David Jin; Hongxing Liu
Journal:  Blood Cancer J       Date:  2021-06-16       Impact factor: 11.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.